UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6126
NeoVolta
NEOV
$153M
| $547K | ﹤0.01% |
173,800
-65,128
| -27% | -$165K |
2024 Q3
7 quarters
|
|
6127
MNTN Inc
MNTN
$399M
| $547K | ﹤0.01% |
59,471
-112,156
| -65% | -$1.02M |
2025 Q2
4 quarters
|
|
6128
PRA Group
PRAA
$486M
| $547K | ﹤0.01% |
28,785
-461,322
| -94% | -$8.2M |
2014 Q4
46 quarters
|
|
6129
Global X Genomics & Biotechnology ETF
GNOM
$102M
| $546K | ﹤0.01% |
9,603
-1,023
| -10% | -$48.8K |
2019 Q4
26 quarters
|
|
6130
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$825M
| $544K | ﹤0.01% |
12,453
+9,926
| +393% | +$476K |
2014 Q4
46 quarters
|
|
6131
Codexis
CDXS
$118M
| $542K | ﹤0.01% |
239,907
-1,943,868
| -89% | -$4.84M |
2016 Q3
39 quarters
|
|
6132
BNY Mellon Strategic Municipal Bond Fund
DSM
$280M
| $542K | ﹤0.01% |
88,101
-4,417
| -5% | -$26.9K |
2014 Q4
46 quarters
|
|
6133
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.07B
| $542K | ﹤0.01% |
13,093
+569
| +5% | +$23.8K |
2026 Q1
1 quarter
|
|
6134
Invesco International Corporate Bond ETF
PICB
$344M
| $539K | ﹤0.01% |
23,294
+4,243
| +22% | +$99.4K |
2014 Q4
46 quarters
|
|
6135
Arrow Financial
AROW
$713M
| $539K | ﹤0.01% |
13,149
-30,960
| -70% | -$1.15M |
2014 Q4
46 quarters
|
|
6136
Faeth Therapeutics
FTH
$570M
| $539K | ﹤0.01% |
21,541
+17,012
| +376% | +$393K |
2026 Q1
1 quarter
|
|
6137
Medifast
MED
$143M
| $533K | ﹤0.01% |
50,223
+36,390
| +263% | +$420K |
2014 Q4
46 quarters
|
|
6138
CALL
Zoetis
ZTS
$32.8B
| $533K | ﹤0.01% |
7,412
+5,634
| +317% | +$530K |
2026 Q1
1 quarter
|
|
6139
CALL
Wave Life Sciences
WVE
$665M
| $531K | ﹤0.01% |
+91,400
| New | +$606K |
2026 Q2
0 quarters
|
|
6140
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$490M
| $530K | ﹤0.01% |
63,150
-2,270
| -3% | -$19.3K |
2014 Q4
46 quarters
|
|
6141
MFS Active Mid Cap ETF
MMID
$35.3M
| $528K | ﹤0.01% |
+20,000
| New | +$511K |
2026 Q2
0 quarters
|
|
6142
Delcath Systems
DCTH
$518M
| $525K | ﹤0.01% |
41,714
-27,425
| -40% | -$303K |
2020 Q2
24 quarters
|
|
6143
MMTec
MTC
$516M
| $524K | ﹤0.01% |
209,791
+137,923
| +192% | +$733K |
2024 Q2
8 quarters
|
|
6144
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.16B
| $524K | ﹤0.01% |
11,981
+6,032
| +101% | +$257K |
2024 Q3
7 quarters
|
|
6145
iShares US Tech Independence Focused ETF
IETC
$586M
| $523K | ﹤0.01% |
4,873
-828
| -15% | -$86.3K |
2025 Q3
3 quarters
|
|
6146
Syntec Optics
OPTX
$196M
| $522K | ﹤0.01% |
41,965
-4,461
| -10% | -$44.5K |
2024 Q1
9 quarters
|
|
6147
Magnachip Semiconductor
MX
$176M
| $522K | ﹤0.01% |
110,336
-73,110
| -40% | -$354K |
2014 Q4
46 quarters
|
|
6148
AB International Low Volatility Equity ETF
ILOW
$1.81B
| $522K | ﹤0.01% |
11,479
+9,700
| +545% | +$434K |
2026 Q1
1 quarter
|
|
6149
Gores Holdings X
GTEN
$471M
| $522K | ﹤0.01% |
50,000
| – | – |
2025 Q4
2 quarters
|
|
6150
Adagene
ADAG
$134M
| $521K | ﹤0.01% |
124,063
+120,061
| +3,000% | +$452K |
2025 Q3
3 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.